ALLIANCEBERNSTEIN L.P. - PROTAGONIST THERAPEUTICS INC ownership

PROTAGONIST THERAPEUTICS INC's ticker is PTGX and the CUSIP is 74366E102. A total of 142 filers reported holding PROTAGONIST THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.34 and the average weighting 0.3%.

Quarter-by-quarter ownership
ALLIANCEBERNSTEIN L.P. ownership history of PROTAGONIST THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$1,455,697
-34.3%
87,272
+8.8%
0.00%0.0%
Q2 2023$2,215,124
+77.7%
80,200
+48.0%
0.00%0.0%
Q1 2023$1,246,600
+110.8%
54,2000.0%0.00%
Q4 2022$591,322
+75.5%
54,200
+35.5%
0.00%
Q3 2022$337,000
-7.4%
40,000
-13.0%
0.00%
Q2 2022$364,000
-87.8%
46,000
-63.6%
0.00%
-100.0%
Q1 2022$2,995,000
+90.8%
126,463
+175.5%
0.00%0.0%
Q4 2021$1,570,000
+93.1%
45,9000.0%0.00%
Q3 2021$813,000
-60.5%
45,9000.0%0.00%
-100.0%
Q2 2021$2,060,000
+159.8%
45,900
+50.0%
0.00%
Q1 2021$793,000
+40.6%
30,600
+9.3%
0.00%
Q4 2020$564,000
+3.1%
28,0000.0%0.00%
Q3 2020$547,000
+10.7%
28,0000.0%0.00%
Q2 2020$494,000
+333.3%
28,000
+73.9%
0.00%
Q1 2020$114,000
+28.1%
16,100
+27.8%
0.00%
Q4 2019$89,000
-41.1%
12,6000.0%0.00%
Q3 2019$151,00012,6000.00%
Other shareholders
PROTAGONIST THERAPEUTICS INC shareholders Q1 2023
NameSharesValueWeighting ↓
Pharmstandard International S.A. 750,632$7,724,00026.59%
BVF INC/IL 2,617,967$26,939,0002.37%
GREAT POINT PARTNERS LLC 982,449$10,109,0001.58%
Alambic Investment Management, L.P. 65,128$670,0000.53%
FARALLON CAPITAL MANAGEMENT LLC 2,243,202$23,083,0000.14%
ALGERT GLOBAL LLC 44,477$458,0000.10%
Monashee Investment Management LLC 42,945$442,0000.09%
Tekla Capital Management LLC 219,042$2,254,0000.08%
Spark Investment Management LLC 138,800$1,428,0000.08%
OXFORD ASSET MANAGEMENT LLP 187,653$1,904,0000.04%
View complete list of PROTAGONIST THERAPEUTICS INC shareholders